Literature DB >> 10704717

Neuropeptide Y blocks anxiogenic-like behavioral action of corticotropin-releasing factor in an operant conflict test and elevated plus maze.

K T Britton1, Y Akwa, M G Spina, G F Koob.   

Abstract

Central administration of neuropeptide Y (NPY) produces anxiolytic-like behavioral effects in rat models of anxiety. Because previous evidence has suggested a relationship between NPY and corticotropin-releasing factor (CRF) in the brain, we have focused on the interaction of these neuropeptide systems in emotional responsiveness to stressful stimuli. Intracerebroventricular administration of CRF produced a marked response suppression in an operant incremental shock conflict paradigm. NPY [(1 microg, intracerebroventricularly (i.c.v.)] significantly antagonized the response-suppressing effects of CRF (0.75 microg, i.c.v.) on punished responding in the conflict test at doses that produced little or no behavioral effect when administered alone. Central administration of the CRF antagonist [D-Phe(12), Nle(21,38),C(alpha) MeLeu(37)]CRF (D-Phe CRF(12-41)) alone did not alter punished or unpunished responding in the conflict test. However, pretreatment with the CRF antagonist before a subthreshold dose of NPY (1 microg, i.c.v.) produced a significant potentiation of the release of punished responding relative to NPY alone and untreated controls. NPY also antagonized the "anxiogenic-like" behavioral effects of CRF in the elevated plus maze. These findings support the hypothesis that NPY and CRF may reciprocally modulate an animal's behavioral response to stressful stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704717     DOI: 10.1016/s0196-9781(99)00169-2

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  18 in total

1.  A functional continuum of regulatory anxiety-enhancing peptides. The search for complexes providing the optimal basis for developing inhibitory therapeutic agents.

Authors:  S V Koroleva; I P Ashmarin
Journal:  Neurosci Behav Physiol       Date:  2006-02

2.  NPY Induces Stress Resilience via Downregulation of Ih in Principal Neurons of Rat Basolateral Amygdala.

Authors:  Heika Silveira Villarroel; Maria Bompolaki; James P Mackay; Ana Pamela Miranda Tapia; Sheldon D Michaelson; Randy J Leitermann; Robert A Marr; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2018-04-12       Impact factor: 6.167

Review 3.  Posttraumatic stress disorder: A metabolic disorder in disguise?

Authors:  Vasiliki Michopoulos; Aimee Vester; Gretchen Neigh
Journal:  Exp Neurol       Date:  2016-05-28       Impact factor: 5.330

Review 4.  The Corticotropin Releasing Factor Receptor 1 in Alcohol Use Disorder: Still a Valid Drug Target?

Authors:  Matthew B Pomrenze; Tracy L Fetterly; Danny G Winder; Robert O Messing
Journal:  Alcohol Clin Exp Res       Date:  2017-10-25       Impact factor: 3.455

5.  Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors.

Authors:  Chantelle J Giesbrecht; James P Mackay; Heika B Silveira; Janice H Urban; William F Colmers
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

6.  The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.

Authors:  Hagit Cohen; Tianmin Liu; Nitsan Kozlovsky; Zeev Kaplan; Joseph Zohar; Aleksander A Mathé
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

Review 7.  Biological studies of post-traumatic stress disorder.

Authors:  Roger K Pitman; Ann M Rasmusson; Karestan C Koenen; Lisa M Shin; Scott P Orr; Mark W Gilbertson; Mohammed R Milad; Israel Liberzon
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

8.  Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Neuropharmacology       Date:  2012-08-31       Impact factor: 5.250

9.  The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment.

Authors:  Dennis S Charney
Journal:  Dialogues Clin Neurosci       Date:  2003-09       Impact factor: 5.986

10.  Differential Regulation of Neuropeptide Y in the Amygdala and Prefrontal Cortex during Recovery from Chronic Variable Stress.

Authors:  Jennifer L McGuire; Lauren E Larke; Floyd R Sallee; James P Herman; Renu Sah
Journal:  Front Behav Neurosci       Date:  2011-09-15       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.